Loading...
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis
Background: Behçet's disease is a multisystem vasculitis of unknown origin. Standard treatment mainly comprises systemic immunosuppressive agents. Ocular involvement, mostly posterior uveitis with retinal vasculitis, leads to blindness in 20–50% of the involved eyes within 5 years. The efficacy...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Copyright 2003 British Journal of Ophthalmology
2003
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1771623/ https://ncbi.nlm.nih.gov/pubmed/12642304 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|